Literature DB >> 14561813

PEP-19 overexpression in human uterine leiomyoma.

Takanobu Kanamori1, Kenji Takakura, Masaki Mandai, Masatoshi Kariya, Ken Fukuhara, Takashi Kusakari, Chika Momma, Hiroaki Shime, Haruhiko Yagi, Mitsunaga Konishi, Ayako Suzuki, Noriomi Matsumura, Kanako Nanbu, Jun Fujita, Shingo Fujii.   

Abstract

Although uterine leiomyomas represent one of the most common neoplasms in adult women, their pathogenesis remains poorly understood. A cDNA microarray analysis was performed to search for candidate genes expressed to a greater degree in leiomyoma compared with matched myometrium. A total of 15 candidate genes was obtained; neuron-specific protein PEP-19 (Purkinje cell protein 4; PCP 4) exhibited a striking difference in expression between leiomyoma and myometrium. Although PEP-19 expression has been reported exclusively in the central nervous system, the present study demonstrated that PEP-19 is also expressed in other human organs, including prostate, kidney and uterus. To clarify the role of PEP-19 in the pathogenesis of leiomyomas, PEP-19 expression was investigated for a series of human leiomyoma, as well as normal myometrium and leiomyosarcoma. PEP-19 mRNA and protein expression were much stronger in leiomyomas compared with normal myometrium, suggesting that PEP-19 might be involved in leiomyoma pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561813     DOI: 10.1093/molehr/gag088

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  15 in total

1.  Intrinsically disordered PEP-19 confers unique dynamic properties to apo and calcium calmodulin.

Authors:  Xu Wang; Quinn K Kleerekoper; Liang-wen Xiong; John A Putkey
Journal:  Biochemistry       Date:  2010-11-12       Impact factor: 3.162

Review 2.  Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.

Authors:  Takuma Hayashi; Akiko Horiuchi; Kenji Sano; Nobuyoshi Hiraoka; Yae Kanai; Tanri Shiozawa; Susumu Tonegawa; Ikuo Konishi
Journal:  Protein Cell       Date:  2010-08-28       Impact factor: 14.870

3.  Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.

Authors:  Ayako Suzuki; Masatoshi Kariya; Noriomi Matsumura; Tsukasa Baba; Haruhiko Yagi; Masaki Mandai; Ikuo Konishi; Shingo Fujii
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

4.  Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.

Authors:  Irina K Dimitrova; Jennifer K Richer; Michael C Rudolph; Nicole S Spoelstra; Elaine M Reno; Theresa M Medina; Andrew P Bradford
Journal:  Fertil Steril       Date:  2008-07-30       Impact factor: 7.329

5.  The calmodulin regulator protein, PEP-19, sensitizes ATP-induced Ca2+ release.

Authors:  Xu Wang; Liang Wen Xiong; Amina El Ayadi; Darren Boehning; John A Putkey
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

6.  Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma.

Authors:  Takuma Hayashi; Akiko Horiuchi; Kenji Sano; Nobuyoshi Hiraoka; Yae Kanai; Tanri Shiozawa; Susumu Tonegawa; Ikuo Konishi
Journal:  Sarcoma       Date:  2011-03-08

7.  Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy.

Authors:  Takuma Hayashi; Akiko Horiuchi; Kenji Sano; Nobuyoshi Hiraoka; Mari Kasai; Tomoyuki Ichimura; Tamotsu Sudo; Yoh-Ichi Tagawa; Ryuichiro Nishimura; Osamu Ishiko; Yae Kanai; Nobuo Yaegashi; Hiroyuki Aburatani; Tanri Shiozawa; Ikuo Konishi
Journal:  Sci Rep       Date:  2011-12-05       Impact factor: 4.379

8.  Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.

Authors:  Takuma Hayashi; Yuto Shimamura; Taro Saegusa; Akiko Horiuchi; Yukihiro Kobayashi; Nobuyoshi Hiraoka; Yae Kanai; Hiroyuki Aburatani; Kenji Sano; Ikuo Konishi
Journal:  Gene Regul Syst Bio       Date:  2008-07-22

9.  Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer.

Authors:  Nicholas Erho; Christine Buerki; Timothy J Triche; Elai Davicioni; Ismael A Vergara
Journal:  J Oncol       Date:  2012-08-16       Impact factor: 4.375

10.  Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression.

Authors:  Tobias Weissenbacher; Thomas Vrekoussis; David Roeder; Antonis Makrigiannakis; Doris Mayr; Nina Ditsch; Klaus Friese; Udo Jeschke; Darius Dian
Journal:  Int J Mol Sci       Date:  2013-02-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.